First EU Citizens Using ePrescriptions in other EU Country
The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a pharmacy in Estonia and retrieve medicine prescribed electronically by their doctor in Finland.
Read more ...
The Health Innovation System is 'Broken' and Failing Patients, Warns UCL Report
Patients in Europe are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.
Read more ...
Clockwork: The Solution that Supports Everyday Life of Shift Workers is Being Tested in Portuguese Hospitals
A pilot study coordinated by researchers from FhP-AICOS (Fraunhofer Portugal AICOS) is encouraging healthcare shift workers to become aware of their physical activity and sleep rhythms, and to reflect about their work and lifestyle, using technology. Clockwork, a tech solution created to achieve this, is already being tested in Portugal at CUF hospitals, and it will get its debut in Hungary soon.
Read more ...
Private Healthcare Data to be Captured by NHS Systems
An initiative has been launched to ensure private healthcare data is recorded in the same way as NHS data in England, with the aim of improving consistency across the system. The Acute Data Alignment Programme (ADAPt) aims to integrate data on privately funded healthcare into NHS systems and standards for the first time.
Read more ...
The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).
Read more ...
The Big Ethical Questions for Artificial Intelligence in Healthcare
AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.
Read more ...
Data in the EU: Commission Steps Up Efforts to Increase Availability and Boost Healthcare Data Sharing
The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal data in the Digital Single Market. Data-driven innovation is a key enabler of market growth, job creation, particularly for SMEs and startups, and the development of new technologies.
Read more ...
The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a pharmacy in Estonia and retrieve medicine prescribed electronically by their doctor in Finland. 
An initiative has been launched to ensure private healthcare data is recorded in the same way as NHS data in England, with the aim of improving consistency across the system. The Acute Data Alignment Programme (ADAPt) aims to integrate data on privately funded healthcare into NHS systems and standards for the first time. 
The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).